Neoadjuvant Chemo-radiation versus Adjuvant Chemotherapy for Locally Advanced Adenocarcinoma of the Rectosigmoid junction.
The optimal treatment approach for adenocarcinoma of the rectosigmoid junction remains unclear. To compare outcomes of NCR and AC for cancer of the rectosigmoid junction. Retrospective cohort study (2004 - 2015) SETTING: Nationwide, hospital-based cancer outcomes data (National Cancer Database). All patients who underwent curative-intent resection for locally advanced (AJCC stages II & III) adenocarcinoma of the rectosigmoid junction were included. Exclusion criteria were age <18 & >75 years, Charlson-Deyo score>2, AJCC stages I, IV, and un-staged tumors. Treatment with NCR versus AC. The primary outcome was overall survival. Other endpoints were resection margin status, the presence of lympho-vascular invasion, and postoperative length of stay. A total of 2,828 patients were included in this study [1,701 (59.7%) received NCR]. NCR was more frequently utilized in patients who were black (10.3% vs 7.6%, p<0.05) and underwent treatment at academic institutions (37.9 vs. 22.5%, p<0.05). Treatment with NCR did not differentially influence survival following risk-adjustment (HR: 1.17, CI: 0.98 - 1.40; p=0.085). NCR was independently associated with a decreased likelihood for positive resection margins (OR: 0.44, CI: 0.33 - 0.58; p<0.001) and lympho-vascular invasion (OR: 0.51, CI: 0.40 - 0.67; p <0.001). However, treatment with NCR was associated with prolonged hospitalization needs when compared to AC (7.3 vs. 6.5 days, p=0.015) LIMITATIONS: Retrospective design, external validity, risk of tumor misclassification CONCLUSIONS: NCR currently seems to be favored over AC for the management of locally advanced adenocarcinoma of the rectosigmoid junction. This approach may not be justified as NCR is associated with prolonged hospitalization needs without a clear survival benefit, when compared to AC. Prospective studies are warranted to definitively compare outcomes of NCR and AC in this patient population.